Scientists developing new
cell therapy methods for the treatment of disorders such as sickle cell disease or leukemia need to consider how their culture conditions may affect the success of their translational research.
The experimental and clinical studies show that different
cell therapy methods lead to different results of efficiency.
Not exact matches
But as new
methods of genetic modification emerge, both the scientific and the sports communities are becoming increasingly aware that gene
therapy — the insertion of genes into an individual's
cells and tissues — will make its way onto the playing field.
Researchers, led by Joshua Mayourian at the Icahn School of Medicine at Mount Sinai, used mathematical modeling to simulate electrical interactions between these stem
cells and heart
cells to develop insight into possible adverse effects, as well as to hypothesize new
methods for reducing some potential risks of this
therapy.
With these in vitro test
methods, the KU researchers have shown that anti-CD44s antibody can reduce pancreatic cancer
cell growth, metastasis and ability of the tumors to recur after radiation
therapy.
In addition to providing insights regarding selection of treatment, this blood test may also prove helpful in assessing the presence of residual disease, recurrence, or relapse and detection of
therapy - resistant cancer
cells more quickly than conventional tissue - based
methods.
«By reprogramming human
cells, scientists have created new opportunities to study diseases and develop
methods for diagnosis and
therapy,» the Nobel judges wrote.
They do not yet form the basis for a
therapy, researchers said, because
methods must still be perfected to get them more selectively into the cancer
cells.
«
Cell - weighing
method could help doctors choose cancer drugs: Technique may predict which
therapies a patient is most sensitive or resistant to.»
«Preventing
cell death from infection: Scientists demonstrate powerful
method to find new
therapies.»
This
method, known as targeted radionuclide
therapy, or TRT, involves the use of molecules labeled with radioactive atoms that are injected into patients and localized in cancer
cells.
The researchers say their
method offers a new explanation for how to prevent cancer
cells from becoming treatment - resistant and how combinations
therapies can be developed to overcome drug resistance.
While this promising treatment
method has been intensively researched over many years, there has so far been only limited practical success in endogenous stem
cell therapy.
Robert Beall becomes CEO of the CFF and, grasping the limitations of gene
therapy, invests $ 3.2 million in Aurora Biosciences Corp., where
cell physiologist Paul Negulescu begins to look for a chemical cure using high - throughput
methods to test large numbers of potential drugs.
However, the study led by Pyle found that the current
methods are inefficient; they produce immature
cells that are not appropriate for modeling Duchenne in the laboratory or creating a
cell replacement
therapy for the disease.
However, a
method to generate
cells that are fully mature — a crucial prerequisite for life - saving
therapies — has proven far more difficult.
Ultimately, this knowledge will be useful for understanding the very early events in human development, which are reflected in the naïve and primed stem
cell states, and could also lead to improved
methods to reprogram human
cells for stem
cell - based
therapies.
So we want to look at possible
methods and
therapies to activate the T -
cells when they need to work,» said Sotomayor.
Although we agree that greater investments are needed in the clinical development of these
therapies, we disagree with the authors» suggestion that, relative to embryonic stem
cells, adult stem
cells provide a superior vehicle for
cell - based
therapies because they lack tumorigenic activity, can be prepared by
methods approved by the Food and Drug Administration (FDA), and have been free of ethical controversy.
This should also enable commercialization of medical devices, reagents, and other products required for
cell therapies through the development and dissemination of innovative
methods and procedures for regenerative medicine based products.
«The objective of the Clinical
Cell Therapy Program is to develop new
methods to regrow heart muscle and blood vessels, and evaluate the efficacy of these
methods as an approach to improving heart function in patients with a variety of heart disorders,» said Anthony DeMaria, M.D., director of the Sulpizio Family Cardiovascular Center at UC San Diego.
The
cell processing track aims at reproducible, safe and sustainable
methods applicable in manufacturing settings for
cell - based products intended for cellular
therapy.
Based on positive results produced from a number of scientific clinical trials, coronary artery disease
therapy using adult stem
cells is a promising new
method of treatment for coronary artery disease patients.
The only plausible
methods of repairing stochastic nuclear DNA damage look to be the aforementioned advanced molecular nanotechnology, something that lies some decades in the future, or major advances in gene
therapy, to the point at which it could be cost - effective and safe to scan and conditionally alter the majority of genes in the majority of
cells all at once.
Lentiviral - based gene
therapy methods to modify human CD34 + hematopoietic stem
cells have been investigated as a way of treating various hematological disorders including X-linked chronic granulomatous disease (X-CGD).
The Bulte Lab has developed
methods to label
cells magnetically using tiny superparamagnetic iron oxide nanoparticles in order to make them visible by magnetic resonance imaging; this technology has now been introduced in the clinic for several
cell therapy applications.
The results described in
Cell Reports underscore the value of the single cell method to evaluate tumor ther
Cell Reports underscore the value of the single
cell method to evaluate tumor ther
cell method to evaluate tumor
therapy.
Dr. Kim's lab also investigates translational stem
cell research and personalized
cell therapy of PD and is optimizing reprogramming and differentiation
methods.
Summary: University of Chicago researchers have developed the first practical
method to limit activity of therapeutic genes to a specific
cell type (smooth muscle
cells), clearing a major safety hurdle facing gene
therapy.
The new iPS
cells generated using novel
methods may represent biomedically - and clinically - ideal
cells, providing potential platforms for studying human disease mechanisms and achieving the long - term goal of personalized
cell - replacement
therapy.
September 1, 1997 Targeting gene
therapy to specific
cells Researchers at the University of Chicago Medical Center have developed the first practical
method to restrict the activity of genes used for gene
therapy to a specific
cell type.
LA JOLLA, CA — A new
method for generating stem
cells from mature
cells promises to boost stem
cell production in the laboratory, helping to remove a barrier to regenerative medicine
therapies...
The scientists say their
method, which repairs the beta - globin gene (HBB), avoids gene
therapy techniques that can introduce potentially harmful genes into
cells.
The
method, called «theranostic» imaging, targets potent drug
therapies directly and only to cancer
cells while also tracking and monitoring the journey.
In two new publications in the journal Molecular
Therapy, University of Cincinnati (UC) biomedical engineering professor Peixuan Guo, PhD, details successful
methods of producing large RNA nanoparticles and testing their safety in the delivery of therapeutics to targeted
cells.
Novocell has developed and proven
methods to efficiently generate pancreatic, insulin - producing
cells from hESCs, demonstrating for the first time that hESCs could serve as a source of cellular
therapy for diabetes.
Developing
methods to deliver
cells and to reduce contamination of hESC - derived product preparations are major concerns impacting the development and application of stem
cell therapies,» said Emmanuel Baetge, Ph.D., Senior Vice President and Chief Scientific Officer of Novocell.
And because each
cell has its own unique set of mutations, we can not solve them with the
methods of gene
therapy in the adult organism either today or tomorrow.
Using state - of - the - art proteomics and associated computational
methods, the Speicher laboratory is investigating protein changes associated with ovarian cancer, melanoma, cardiac injury resulting from breast cancer
therapies, ectopic pregnancy, red
cell diseases, and other clinical disorders.
All these
methods pave the way for stem
cell therapies for a plethora of conditions.
Yes, I'm sticking to the fringe stuff early in this chapter — and stem
cell therapy certainly is another potent recovery
method that flies under the radar.
4) Gene
therapy is a set of
methods that uses genes to treat or prevent disease by inserting genes into a patient's
cells.
While osteoarthritic conditions are rather difficult to treat, stem
cell therapy offers an effective alternative for pets that have not tolerated or responded well to medication, are not good surgical candidates, require long - term pain management, and / or for whom a natural
therapy is a preferred
method of treatment.
Our veterinarians implement this revolutionary
method of pet
therapy by taking «blank slate»
cells and using them to treat spinal cord, bone, ligament, and tendon injuries.
Preparation and global prosecution of patent applications directed to diagnostic and therapeutic products including antibodies, gene
therapies, vaccines, stem
cells, pharmaceutical formulations, nanotechnology, nucleic acid molecules, biologics, medical devices, mouse platforms for antibody development, and
methods of treating diseases.